These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34823454)

  • 1. Human Defensins from Antivirals to Vaccine Adjuvants: Rediscovery of the Innate Immunity Arsenal.
    Zupin L; Crovella S
    Protein Pept Lett; 2022; 29(2):121-124. PubMed ID: 34823454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human Defensins Inhibit SARS-CoV-2 Infection by Blocking Viral Entry.
    Xu C; Wang A; Marin M; Honnen W; Ramasamy S; Porter E; Subbian S; Pinter A; Melikyan GB; Lu W; Chang TL
    Viruses; 2021 Jun; 13(7):. PubMed ID: 34206990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promising role of defensins peptides as therapeutics to combat against viral infection.
    Solanki SS; Singh P; Kashyap P; Sansi MS; Ali SA
    Microb Pathog; 2021 Jun; 155():104930. PubMed ID: 33933603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA Oligonucleotides as Antivirals and Vaccine Constituents against SARS Coronaviruses: A Prospective Tool for Immune System Tuning.
    Oberemok VV; Andreeva OA; Alieva EE
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of SARS-CoV-2 Infection by Human Defensin HNP1 and Retrocyclin RC-101.
    Kudryashova E; Zani A; Vilmen G; Sharma A; Lu W; Yount JS; Kudryashov DS
    J Mol Biol; 2022 Mar; 434(6):167225. PubMed ID: 34487793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identifying enhancers of innate immune signaling as broad-spectrum antivirals active against emerging viruses.
    Maarifi G; Martin MF; Zebboudj A; Boulay A; Nouaux P; Fernandez J; Lagisquet J; Garcin D; Gaudin R; Arhel NJ; Nisole S
    Cell Chem Biol; 2022 Jul; 29(7):1113-1125.e6. PubMed ID: 35728599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human β-defensin 2 plays a regulatory role in innate antiviral immunity and is capable of potentiating the induction of antigen-specific immunity.
    Kim J; Yang YL; Jang SH; Jang YS
    Virol J; 2018 Aug; 15(1):124. PubMed ID: 30089512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of innate immunity related genes resulting in prophylactic antimicrobial and antiviral properties.
    Ferrucci V; Miceli M; Pagliuca C; Bianco O; Castaldo L; Izzo L; Cozzolino M; Zannella C; Oglio F; Polcaro A; Randazzo A; Colicchio R; Galdiero M; Berni Canani R; Salvatore P; Zollo M
    J Transl Med; 2024 Jun; 22(1):574. PubMed ID: 38886736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The seven constitutive respiratory defense barriers against SARS-CoV-2 infection.
    Tosta E
    Rev Soc Bras Med Trop; 2021; 54():e04612021. PubMed ID: 34932765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of defensin genes during SARS-CoV-2 infection.
    Idris MM; Banu S; Siva AB; Nagaraj R
    Acta Virol; 2022; 66(3):249-253. PubMed ID: 36029089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aminoglycosides can be a better choice over macrolides in COVID-19 regimen: Plausible mechanism for repurposing strategy.
    Chalichem NSS; Bethapudi B; Mundkinajeddu D
    Med Hypotheses; 2020 Nov; 144():109984. PubMed ID: 32554149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-Glucans Could Be Adjuvants for SARS-CoV-2 Virus Vaccines (COVID-19).
    Córdova-Martínez A; Caballero-García A; Roche E; Noriega DC
    Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards the Application of Human Defensins as Antivirals.
    Park MS; Kim JI; Lee I; Park S; Bae JY; Park MS
    Biomol Ther (Seoul); 2018 May; 26(3):242-254. PubMed ID: 29310427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defensins in viral infections.
    Ding J; Chou YY; Chang TL
    J Innate Immun; 2009; 1(5):413-20. PubMed ID: 20375599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential Antiviral Immune Response Against COVID-19: Lessons Learned from SARS-CoV.
    Akbarpour M; Sharifi L; Safdarian AR; Farhangnia P; Borjkhani M; Rezaei N
    Adv Exp Med Biol; 2021; 1318():149-167. PubMed ID: 33973177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viral Evasion of the Complement System and Its Importance for Vaccines and Therapeutics.
    Mellors J; Tipton T; Longet S; Carroll M
    Front Immunol; 2020; 11():1450. PubMed ID: 32733480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defensins in Viral Infection and Pathogenesis.
    Holly MK; Diaz K; Smith JG
    Annu Rev Virol; 2017 Sep; 4(1):369-391. PubMed ID: 28715972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of Aerosol Delivered BCG Vaccination on Immunological and Disease Parameters Following SARS-CoV-2 Challenge in Rhesus Macaques.
    White AD; Sibley L; Sarfas C; Morrison AL; Bewley K; Churchward C; Fotheringham S; Gkolfinos K; Gooch K; Handley A; Humphries HE; Hunter L; Kennard C; Longet S; Mabbutt A; Moffatt M; Rayner E; Tipton T; Watson R; Hall Y; Bodman-Smith M; Gleeson F; Dennis M; Salguero FJ; Carroll M; McShane H; Cookson W; Hopkin J; Sharpe S
    Front Immunol; 2021; 12():801799. PubMed ID: 35222355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel and potent inhibitors targeting DHODH are broad-spectrum antivirals against RNA viruses including newly-emerged coronavirus SARS-CoV-2.
    Xiong R; Zhang L; Li S; Sun Y; Ding M; Wang Y; Zhao Y; Wu Y; Shang W; Jiang X; Shan J; Shen Z; Tong Y; Xu L; Chen Y; Liu Y; Zou G; Lavillete D; Zhao Z; Wang R; Zhu L; Xiao G; Lan K; Li H; Xu K
    Protein Cell; 2020 Oct; 11(10):723-739. PubMed ID: 32754890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiviral Activities of Human Host Defense Peptides.
    Brice DC; Diamond G
    Curr Med Chem; 2020; 27(9):1420-1443. PubMed ID: 31385762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.